Pharmaceutical News

RSS

Ipsen, Inspiration receive positive opinion in Europe for orphan drug status of OBI-1 in treatment of hemophilia

Ipsen and Inspiration Biopharmaceuticals, Inc. announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia.

17 Jun 2010

Gabapentin shows effective in patients with locked-in syndrome, opsoclonus-myoclonus syndrome

For patients with quadriplegia, mutism and lower cranial nerve paralysis (locked-in syndrome), their only means of interacting with others is through vertical gaze and upper eyelid movements, using eye-coded communication strategies.

17 Jun 2010

FDA: Potential risk of overdosing infants with liquid vitamin D

Some liquid vitamin D supplement products come with droppers that could allow parents and caregivers to accidentally give harmful amounts of the vitamin to an infant. These droppers can hold a greater amount of liquid vitamin D than an infant should receive.

17 Jun 2010

Fertility drugs cause multiple and premature births

The widespread use of fertility drugs, not just high-tech laboratory procedures, plays a major role in causing multiple births and contributes to the problem of premature birth in the United States, experts said today at the March of Dimes National Communications Advisory Council luncheon.

17 Jun 2010

New drug application for ulipristal acetate as emergency contraceptive misleading, says Family Research Council

Tomorrow, the Food and Drug Administration (FDA) will hold a hearing to consider approval of a new drug application for an abortifacient drug, ulipristal acetate, as an emergency contraceptive, or a new "Plan B."

17 Jun 2010

UF doctors administer newly available therapy for late-onset Pompe disease

The first commercially available treatment in the United States for patients with late-onset Pompe disease was administered today (Wednesday, June 16) at the University of Florida.

17 Jun 2010

IRX Therapeutics raises $8M to further develop pipeline of cancer vaccine candidates

IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.

17 Jun 2010

BioNeutral announces distribution collaboration for sporicidal formulations with Steri-7

BioNeutral Group, Inc., a specialty chemical technology-based life science company, announced today that in collaboration with Steri-7™, a UK-based specialty chemical health care company, it will be expanding availability of its sporicidal formulations in the UK, Europe and the Middle East. Steri-7™ recently obtained approval from the UK's National Health Service (NHS) to market its formulations as a sporicidal cleaner/wipe.

17 Jun 2010

USPTO issues patent covering Probuphine for opiate addiction

Titan Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued patent number 7,736,665 covering Probuphine for the treatment of opiate addiction.

16 Jun 2010

Oncodesign announces technology license agreement with Janssen Pharmaceutica

Oncodesign Biotechnology(R) announced today that it has signed a licensing agreement with Janssen Pharmaceutica NV (hereinafter Janssen) related to Janssen’s macrocyclic chemistry technology. Oncodesign will have exclusive access to this technology for six years.

16 Jun 2010

Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Decision Resources

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the breast cancer drug market in Brazil will grow from $424 million in 2009 to $611 million in 2014. Factors promoting the market's growth include steady increases in the number of incident breast cancer cases, shifts toward higher-cost chemotherapy and hormonal regimens in the adjuvant setting and increases in the use of targeted therapies following novel product launches and label extensions.

16 Jun 2010

VIVUS to present data on Qnexa at ENDO meeting

VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."

16 Jun 2010

Report reveals increase in patients influence on success, failure of new drugs

Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs - according to a newly published New Health Report commissioned by Quintiles to gauge the opinions of biopharma executives, managed care executives and patients, and to track progress in the New Health.

16 Jun 2010

Differences in reproductive strategies drive individuals' views on recreational drugs: Study

Why is there so much disagreement about whether using recreational drugs is morally wrong? A University of Pennsylvania psychology study shows that the debate about drugs might really be about sex.

16 Jun 2010

Nordic Naturals introduces Omega Probiotic for optimal digestive and gastrointestinal health

Nordic Naturals, the industry leader in omega-3 fish oil, introduces Omega Probiotic, a synergistic blend of fish oil and live probiotic spores for optimal digestive and gastrointestinal health. The breakthrough formula combines two important nutrients that are commonly lacking in today's modern diet in one easy-to-take supplement that does not require refrigeration.

16 Jun 2010

Report on treatment trends in systemic lupus erythematosus

BioTrends is pleased to announce the upcoming publication of a new syndicated report, TreatmentTrends®: Systemic Lupus Erythematosus (SLE). This report will provide a comprehensive market overview of current and future treatment trends in SLE based on a primary research study fielded with 102 rheumatologists in the U.S. during the first week in June.

16 Jun 2010

Physicians play stronger role in ensuring asthma patients don't waver in taking drugs: Researchers

Armed with the right information, physicians can play a stronger role in ensuring asthma patients don't waver in taking drugs proven to prevent asthma attacks, according to researchers at Henry Ford Hospital in Detroit.

16 Jun 2010

FDA unveils safety reports on recently approved drugs, biologics

The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.

16 Jun 2010

Microneedle skin patches as effective as hypodermic needles for flu vaccination

Flu vaccine delivered through skin patches containing microneedles has proven at least as effective at preventing influenza in mice as intramuscular, hypodermic flu immunization.

16 Jun 2010

Vaccination against 2009 H1N1 influenza virus may also protect against 1918 Spanish influenza virus

Researchers at Mount Sinai School of Medicine have determined people who were vaccinated against the 2009 H1N1 influenza virus may also be protected against the lethal 1918 Spanish influenza virus, which killed more than 50 million people worldwide. The new findings are published in the current issue of Nature Communications.

16 Jun 2010

Pharmaceutical News

Ipsen, Inspiration receive positive opinion in Europe for orphan drug status of OBI-1 in treatment of hemophilia

Gabapentin shows effective in patients with locked-in syndrome, opsoclonus-myoclonus syndrome

FDA: Potential risk of overdosing infants with liquid vitamin D

Fertility drugs cause multiple and premature births

New drug application for ulipristal acetate as emergency contraceptive misleading, says Family Research Council

UF doctors administer newly available therapy for late-onset Pompe disease

IRX Therapeutics raises $8M to further develop pipeline of cancer vaccine candidates

BioNeutral announces distribution collaboration for sporicidal formulations with Steri-7

USPTO issues patent covering Probuphine for opiate addiction

Oncodesign announces technology license agreement with Janssen Pharmaceutica

Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Decision Resources

VIVUS to present data on Qnexa at ENDO meeting

Report reveals increase in patients influence on success, failure of new drugs

Differences in reproductive strategies drive individuals' views on recreational drugs: Study

Nordic Naturals introduces Omega Probiotic for optimal digestive and gastrointestinal health

Report on treatment trends in systemic lupus erythematosus

Physicians play stronger role in ensuring asthma patients don't waver in taking drugs: Researchers

FDA unveils safety reports on recently approved drugs, biologics

Microneedle skin patches as effective as hypodermic needles for flu vaccination

Vaccination against 2009 H1N1 influenza virus may also protect against 1918 Spanish influenza virus

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News